About
Psychedelic Medicines
Areas of Focus
Categories
Small Molecule PharmaceuticalPsychedelicNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
70
By Phase
PHASE2: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06309277Lead Sponsor
A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD
PHASE2Recruiting
30 participants
Started: Feb 1, 2024 · Completed: Jul 31, 2024
NCT06236880Lead Sponsor
A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD
PHASE2Recruiting
40 participants
Started: Jan 31, 2024 · Completed: Jul 29, 2024
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...